BRIEF published on 04/01/2026 at 18:05, 2 months 24 days ago EXACOMPTA CLAIREFONTAINE annonce des résultats financiers en baisse pour 2025 Résultats Financiers Baisse Des Revenus Marché De La Papeterie Perspectives 2026 Segment Papier
BRIEF published on 04/01/2026 at 18:05, 2 months 24 days ago EXACOMPTA CLAIREFONTAINE Reports Decline in 2025 Financial Results Financial Results Revenue Decline Stationery Market 2026 Outlook Paper Segment
REGULATED PRESS RELEASE published on 04/01/2026 at 18:00, 2 months 24 days ago Financial statements - 31 december 2025 EXACOMPTA CLAIREFONTAINE Board of Directors reviewed and approved 2025 financial statements, highlighting revenue and operating income figures. Economic conditions and outlook also discussed Financial Statements Revenue Operating Income Exacompta Clairefontaine Economic Conditions
BRIEF published on 03/26/2026 at 18:05, 2 months 30 days ago EXACOMPTA CLAIREFONTAINE : Bilan 2025 et Prévisions pour 2026 Chiffre D'affaires Résultat Opérationnel Marché Papeterie Coûts Énergétiques Perspectives 2026
BRIEF published on 03/26/2026 at 18:05, 2 months 30 days ago EXACOMPTA CLAIREFONTAINE: 2025 Review and 2026 Forecast Revenue Stationery Market Energy Costs Outlook 2026 Operational Result
REGULATED PRESS RELEASE published on 03/26/2026 at 18:00, 2 months 30 days ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026 Résumé des résultats financiers et perspectives d'Exacompta Clairefontaine pour 2025 et 2026 Résultats Financiers Assemblée Générale Dividende Perspectives Exacompta Clairefontaine
BRIEF published on 01/07/2026 at 18:05, 5 months 18 days ago Exacompta Clairefontaine: Voting Rights and Shares in 2025 Share Capital Voting Rights Actions Exacompta Clairefontaine Self-monitoring
BRIEF published on 01/07/2026 at 18:05, 5 months 18 days ago Exacompta Clairefontaine : Droits de Vote et Actions en 2025 Droits De Vote Capital Social Actions Exacompta Clairefontaine Autocontrôle
REGULATED PRESS RELEASE published on 01/07/2026 at 18:00, 5 months 18 days ago Droits de vote et actions 2025 Déclaration du nombre total de droits de vote et d'actions composant le capital de la société EXACOMPTA CLAIREFONTAINE au cours de l'année 2025 Capital Déclaration Droits De Vote Actions Exacompta Clairefontaine
REGULATED PRESS RELEASE published on 10/01/2025 at 18:15, 8 months 24 days ago Financial statements - 30 june 2025
Published on 06/26/2026 at 01:40, 8 hours 26 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 10 hours 36 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 11 hours 36 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 12 hours 34 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 18 hours 36 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 09:59, 7 minutes ago AGRANA finalises sale of Leopoldsdorf areal to PCS Holding
Published on 06/26/2026 at 09:43, 23 minutes ago ABO Energy secures wind energy tariffs and achieves further successes
Published on 06/26/2026 at 09:41, 25 minutes ago Emerald Horizon AG begins trading on the Vienna Stock Exchange
Published on 06/26/2026 at 09:26, 40 minutes ago Hamburg Direct Bank wins two German Brand Awards 2026
Published on 06/26/2026 at 09:25, 41 minutes ago SKYWORTH Solar Shines at Intersolar Europe 2026, Shaping the Future of Energy in Europe with a Comprehensive Product Matrix
Published on 06/26/2026 at 07:00, 3 hours 6 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 3 hours 6 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 15 hours 21 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 15 hours 36 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 16 hours 16 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
